Combined human IL-18 and pazopanib cancer treatment

• 1. 盐酸帕唑帕尼在制备治疗肺纤维化疾病药物中的应用 [P] . 中国专利： CN109793740A . 2019-05-24
• 2. 一种帕唑帕尼三聚体杂质中间体的合成方法 [P] . 中国专利： CN113979835A . 2022-01-28
• 3. METHODS OF TREATING CANCER BY ADMINISTERING A HUMAN IL-18 AND PAZOPANIB COMBINATION [P] . NZ579179A . 2011-12-22

  机译： 简化人类IL-18与帕唑帕尼组合治疗癌症的方法

• 4. Combined Human IL-18 and anti CD20 antibody cancer treatment [P] . ZA200906292B . 2010-07-28

  机译： 联合人类IL-18和抗CD20抗体的癌症治疗

• 5. COMBINED HUMAN IL-18 AND ANTI CD20 ANTIBODY CANCER TREATMENT [P] . 韩国专利： KR20100015798A . 2010-02-12

  机译： 联合人类IL-18和抗CD20抗体治疗

• 1. Assessment of the serum tumor markers and lesion cancer cell proliferation after Nimotuzumab combined with cisplatin and radiotherapy treatment of middle-advanced cervical cancer [J] . Yi Xu, Yuan-Dong Huang, Gui-Lin Zeng 海南医科大学学报（英文版） . 2017,第009期
• 2. A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study) [J] . Pautier P., Penel N., Ray-Coquard I., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第1期
• 3. Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer. [J] . Hashimoto K, Man S, Xu P, Molecular cancer therapeutics . 2010,第4期
• 4. Sequential Versus Combined Treatment of Human Breast Cancer Cells with Antiestrogens and the Vitamin D Analogue EB1089 and Evaluation of Predictive Markers for Vitamin D Treatment. [J] . Christensen GL, Jepsen JS, Fog CK, Breast cancer research and treatment. . 2004,第1期
• 5. Protection of mice by combined treatment with IL-12 and IL-18 against pulmonary and disseminated infection with cryptococcus enoformans [C] . M.H.Qureshi, K.Kawakami, T.Zhang, Proceedings of the Fourth China-Jpan international congress of mycology . 1998
• 6. Smart Brachytherapy Spacers for Combined Chemo-Radiation Therapy: Local Delivery of Nanoparticles, Chemotherapeutics, and Molecular Inhibitors for Cancer Treatment [D] . Belz, Jodi Elizabeth. 2017
• 7. Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer [O] . Kae Hashimoto, Shan Man, Ping Xu, -1
• 8. Anti-Proliferative Effects on Human Colon Cancer Cells of Combined Treatment with Cationic Liposome-Entrapped Human Interferon-.BETA. or -.GAMMA. Gene and Anti-Cancer Drug. [O] . Minoru SHIMIZU, Seiji AKIYAMA, Katsuki ITO, 1997

• 1. Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer [J] . Maya M Moubarak ,Nour Chanouha ,Najwa Abou Ibrahim . 世界临床肿瘤学杂志：英文版 . 2021,第5期
• 2. Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo [J] . Qi Xie ,Min-Yi Wu ,Ding-Xuan Zhang . 世界胃肠病学杂志：英文版 . 2016,第32期
• 3. Isolation and Identification of Cancer Stem Cells from Human Osteosarcom by Serum-free Three-dimensional Culture Combined with Anticancer Drugs [J] . Song ZHOU ,Feng LI ,Jun XIAO . 华中科技大学学报（医学）（英德文版） . 2010,第001期
• 4. Isolation and Identification of Cancer Stem Cells from Human Osteosarcom by Serum-free Three-dimensional Culture Combined with Anticancer Drugs [J] . 周松 ,李锋 ,肖骏 . 华中科技大学学报：医学英德文版 . 2010,第001期
• 5. 帕唑帕尼对非小细胞肺癌PI3K/Akt和Ras/Raf/MEK/ERK通路的影响 [C] . 沈旺 ,尤嘉琮 ,李洋 . 第13届全国肺癌学术大会 . 2013
• 6. 帕唑帕尼影响肺癌表达谱和miRNA谱的联合分析和代谢研究 [A] . 杨帆 . 2016